Characteristic | Protocol A | Protocol B | p-value |
---|---|---|---|
Number of patients | 23 | 14 | |
Age (median, range [years]) | 70 (53–83) | 72.5 (48–86) | 0.61 |
Gender (male/female) | 15/8 | 6/8 | 0.31 |
PS (0/1/2) | 13/9/1 | 10/4/0 | |
Tumor location (head/body-tail) | 9/14 | 10/4 | 0.091 |
Pretreatment CA19-9[U/ml] | 298 (8.7–2368) | 280 (6.1–2715) | 0.96 |
GTV (median, range[cm3]) | 31.46 (10.8–89.6) | 21.65 (2.4–86.5) | 0.11 |
PTV (median, range[cm3]) | 212.6 (146.2–483.4) | 193 (129.4–452.3) | 0.38 |
Overlap* (median, range[cm3]) | 43.8 (12.4–105.2) | 33.8 (9.7–85.4) | 0.067 |
Induction Chemo-regimen (GEM/S1/ mFOLFIRINOX/GnP) | 12/2/3/6 | 7/2/0/5 | |
Concurrent Chemo-regimen (GEM/S1) | 19/4 | 12/2 | 1 |
PPI prescription** | 21 | 14 | 0.51 |
NSAIDs prescription *** | 3 | 2 | 1 |